Trial Profile
Imiquimod/BTIC Lysate-Based Vaccine Immunotherapy for Diffuse Intrinsic Pontine Glioma in Children and Young Adults
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2020
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Brain cancer vaccine
- Indications Diffuse intrinsic pontine glioma; Glioblastoma; Glioma
- Focus Adverse reactions
- 16 Mar 2020 Status changed from suspended to discontinued.
- 11 Nov 2019 Planned End Date changed from 10 Oct 2019 to 10 Feb 2020.
- 12 Feb 2019 Planned End Date changed from 1 Aug 2017 to 10 Oct 2019.